Alle Studien
RekrutierungBEOBACHTEND

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

This study focuses on people with a condition called Hereditary Haemorrhagic Telangiectasia, often shortened to HHT. It's a condition that can cause problems with blood vessels. Researchers at Hammersmith Hospital in London are reviewing existing health records of patients they have treated over many years. This isn't a new treatment or experiment; it's about looking back at information already collected during regular patient care. They want to see if they can find patterns. For example, they're trying to figure out if certain characteristics of people with HHT mean they are more likely to have complications like strokes, brain infections, issues during pregnancy, or high blood pressure in the lungs. This review helps them learn more about HHT and potentially improve care in the future.

Auf einen Blick

Status
Rekrutierung
Sponsor
Imperial College London
Einschreibeziel
2,000
Starten
01 Jan 2000
Geschätzte Fertigstellung
01 Jan 2028

Worum geht es in dieser Studie?

This study is about a health condition called Hereditary Haemorrhagic Telangiectasia, or HHT for short. It's a condition that affects blood vessels throughout the body.

The team at Hammersmith Hospital in London has a special clinic for people with HHT and a related problem called pulmonary arteriovenous malformations (which are unusual connections between blood vessels in the lungs). They've been gathering information about their patients as part of their routine care since 1985. This study isn't about giving you new medicines or treatments; instead, it's about looking back at all that existing information.

The main goal is to understand if certain types of people with HHT are more likely to develop specific health problems. For example, they want to see if some patients are more at risk of having strokes, brain infections, complications during pregnancy, or high blood pressure in the lungs. By looking through these past records, researchers hope to identify clues that could help them predict who might be more susceptible to these issues. This knowledge can then be used to potentially offer better and more personalised care to people with HHT in the future.

Wichtige Erkenntnisse

  • This study reviews existing medical records, not new treatments.
  • It aims to understand HHT complications better.
  • Data comes from HHT patients treated at Hammersmith Hospital.
  • No active participation is required from patients.
  • The goal is to improve future HHT patient care.

Wer könnte berechtigt sein?

This study is reviewing information from people who have already been treated at Hammersmith Hospital in London. It includes individuals with Hereditary Haemorrhagic Telangiectasia (HHT).

If you have HHT and have received care at Hammersmith Hospital, your records might be included in this review.

There are no specific reasons why someone would be excluded from having their records included, as long as they were a patient at Hammersmith Hospital with HHT.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Have you been diagnosed with Hereditary Haemorrhagic Telangiectasia (HHT)?
  2. Have you received care for your HHT at Hammersmith Hospital in London?
  3. Were your medical records created as part of your standard care at the hospital?
  4. Do you understand that this study is looking at past information, not new treatments?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

You won't need to do anything new for this study, as it involves reviewing information that has already been collected during your past visits and care at Hammersmith Hospital. You won't have any extra appointments, tests, or medication as part of this research. Your doctor will simply be looking at your existing medical notes.

Potenzielle Risiken und Vorteile

There are no direct risks to you from this study, as no new tests or treatments are involved. The study is simply looking at your existing medical historical information. The potential benefit is that by understanding more about HHT, doctors may be able to better predict and manage complications for future patients. You have the right to ask if your records are part of this study and, if so, to discuss any concerns with your healthcare team.

Standorte (1)

  • Respiratory Medicine, Hammersmith Hospital
    Verifizierte Postleitzahl
    London, Vereinigtes Königreich· Rekrutierung

Häufige Fragen

What is Hereditary Haemorrhagic Telangiectasia (HHT)?

HHT is a genetic condition that affects blood vessels, which can cause them to be fragile and bleed easily, or to form in unusual ways.

Do I need to do anything if I'm included in this study?

No, you don't need to do anything. This study is reviewing existing patient records, not asking you to take part in new activities.

Will my personal details be kept private?

Yes, all studies involving patient information are required to protect your privacy and use anonymous data where possible.

Who is conducting this study?

The study is being conducted by researchers at Hammersmith Hospital in London.

Why is this research important?

It's important because it helps doctors learn more about HHT and its complications, which could lead to better care for patients in the future.

Wie Sie mehr erfahren können

Claire L Shovlin

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "Case Notes Review on Patients With Hereditary Haemorrhagic T… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.